Skip to main content
. 2021 Jun 1;406(5):1499–1509. doi: 10.1007/s00423-021-02154-4

Table 1.

Patient characteristics

Resected perihilar cholangiocarcinoma
n = 231
Age 1 65 (33–83)
BMI 1 24.5 (16–41)
Gender (male) 2 156 (60)
ASA score 2
1 12 (5)
2 130 (56)
3 85 (37)
4 4 (2)
Bismuth-Corlette 2
I 8 (4)
II 17 (7)
IIIa 55 (24)
IIIb 44 (19)
IV 100 (43)
UICC stage 2
I 10 (4)
II 79 (34)
IIIa 31 (13)
IIIb 104 (45)
IVa 7 (3)
IVb 0 (0)
Resection margin 2
R0 154 (68)
R1 73 (32)
Lymph node status 2
N0 122 (53)
N+ 109 (47)
Microvascular invasion 2
Yes 41 (20)
No 160 (80)
Histopathological grading 2
Grade 1 11 (5)
Grade 2 153 (67)
Grade 3 63 (28)
Perineural sheath infiltration 2
Yes 164 (90)
No 20 (11)
Lymphangitis carcinomatosa 2
Yes 89 (46)
No 106 (54)
T Stage 2
1 16 (7)
2a 63 (27)
2b 67 (29)
3 78 (34)
4 7 (3)
Resection side 2
Left hepatectomy 86 (37)
Extended left hepatectomy 15 (7)
Left trisectionectomy 71 (31)
Right hepatectomy 145 (63)
Extended right hepatectomy 6 (3)
Right trisectionectomy 139 (60)
Surgical approach 2
Standard major hepatectomy 111 (48)
Hilar en bloc resection 120 (52)
Portal vein resection 2
Yes 136 (59)
No 95 (41)
Complications (Clavien-Dindo) 2
None 28 (12)
I 11 (5)
II 51 (22)
IIIa 62 (27)
IIIb 41 (18)
IVa 6 (3)
IVb 1 (0)
V 31 (12)
CA 19-9 (kU/l) 1 63.0 (1–32670)
ICU stay (days) 1 4 (2–123)
Hospital stay (days) 1 23.0 (7–213)
30-day mortality 2 16 (7%)
90-day mortality 2 29 (13)
Hospital readmission 48 (21)
Adjuvant chemotherapy
Yes 39 (18)
No 182 (82)
Recurrence / Death 2 176 (76)

1 Data is presented as median and range. 2 Data is presented as count and proportions (%)